Prostate cancer is the most commonly diagnosed cancer in Australian men. More than 60 men die each week from prostate cancer. Our research is helping to change those outcomes.
Through clinical translational research, laboratory based discovery, and clinical trials, we are improving the diagnosis, treatment, management, and prevention of prostate cancer.
With a research effort spanning across Cabrini and Monash University, our team focuses on understanding the biology of prostate cancer, discovering why patients respond differently to treatments, identifying how to effectively use imaging to detect and stage prostate cancer, and developing accurate disease progression risk stratification models.
Our research will help improve treatments and enable clinicians to design individualised treatment and disease management plans, saving patients from unnecessary treatments and procedures and ensuring those who really need it are fast tracked onto treatment protocols.